CLEVELAND, Dec. 4, 2008 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will participate at the RBC Capital Markets 2008 Healthcare Conference, to be held December 10-11, 2008, at the Westin Times Square hotel in New York City.
Gil Van Bokkelen, Chairman and Chief Executive of Athersys, will participate on a panel entitled "Shrinking the Obesity Epidemic" on Wednesday, December 10th, at 11:00 AM (Eastern Time). Investors may listen to a live audio webcast of the panel moderated by RBC's Ken Trobovich by accessing the following link: http://www.wsw.com/webcast/rbc95/panel6/.
A webcast replay of the presentation can be accessed via the company's web site at: www.athersys.com, under the Investors section.
About Athersys, Inc.
Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. In addition to its lead product candidate, ATHX-105, the Company is developing other orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders. Athersys is also developing MultiStem(r), a patented, adult-derived "off-the-shelf" stem cell product platform for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation/oncology support, ischemic stroke and other indications. More information is available at www.athersys.com.
The Athersys, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4548